Sergei Timofeevski

4.6k total citations
17 papers, 606 citations indexed

About

Sergei Timofeevski is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sergei Timofeevski has authored 17 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sergei Timofeevski's work include PI3K/AKT/mTOR signaling in cancer (4 papers), Enzyme-mediated dye degradation (3 papers) and Melanoma and MAPK Pathways (3 papers). Sergei Timofeevski is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (4 papers), Enzyme-mediated dye degradation (3 papers) and Melanoma and MAPK Pathways (3 papers). Sergei Timofeevski collaborates with scholars based in United States, Switzerland and China. Sergei Timofeevski's co-authors include Steven D. Aust, Michael D. Cameron, N. Scott Reading, Michele McTigue, Brion W. Murray, Helen Y. Zou, James G. Christensen, Ping Chen, Junli Feng and Ted W. Johnson and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.

In The Last Decade

Sergei Timofeevski

17 papers receiving 587 citations

Peers

Sergei Timofeevski
Sergei Timofeevski
Citations per year, relative to Sergei Timofeevski Sergei Timofeevski (= 1×) peers Wenhai Zhang

Countries citing papers authored by Sergei Timofeevski

Since Specialization
Citations

This map shows the geographic impact of Sergei Timofeevski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergei Timofeevski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergei Timofeevski more than expected).

Fields of papers citing papers by Sergei Timofeevski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergei Timofeevski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergei Timofeevski. The network helps show where Sergei Timofeevski may publish in the future.

Co-authorship network of co-authors of Sergei Timofeevski

This figure shows the co-authorship network connecting the top 25 collaborators of Sergei Timofeevski. A scholar is included among the top collaborators of Sergei Timofeevski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergei Timofeevski. Sergei Timofeevski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Johnson, Eric F., Michele McTigue, Rebecca A. Gallego, et al.. (2019). Multiple conformational states of the HPK1 kinase domain in complex with sunitinib reveal the structural changes accompanying HPK1 trans-regulation. Journal of Biological Chemistry. 294(23). 9029–9036. 21 indexed citations
2.
Johnson, Ted W., Ben Bolaños, Alexei Brooun, et al.. (2018). Reviving B-Factors: Activating ALK Mutations Increase Protein Dynamics of the Unphosphorylated Kinase. ACS Medicinal Chemistry Letters. 9(9). 872–877. 6 indexed citations
3.
Gajiwala, K.S., Neil B. Grodsky, Ben Bolaños, et al.. (2017). The Axl kinase domain in complex with a macrocyclic inhibitor offers first structural insights into an active TAM receptor kinase. Journal of Biological Chemistry. 292(38). 15705–15716. 41 indexed citations
4.
Martínez, Ricardo, Alessandra Blasina, Jill Hallin, et al.. (2015). Mitotic Checkpoint Kinase Mps1 Has a Role in Normal Physiology which Impacts Clinical Utility. PLoS ONE. 10(9). e0138616–e0138616. 29 indexed citations
5.
Chen, Ping, Ya‐Li Deng, Simon Bergqvist, et al.. (2014). Engineering of an isolated p110α subunit of PI3Kα permits crystallization and provides a platform for structure‐based drug design. Protein Science. 23(10). 1332–1340. 22 indexed citations
6.
Falk, Matthew D., Wei Liu, Ben Bolaños, et al.. (2014). Enzyme kinetics and distinct modulation of the protein kinase N family of kinases by lipid activators and small molecule inhibitors. Bioscience Reports. 34(2). 18 indexed citations
7.
8.
Zou, Helen Y., Qiuhua Li, Joseph H. Lee, et al.. (2012). Sensitivity of Selected Human Tumor Models to PF-04217903, a Novel Selective c-Met Kinase Inhibitor. Molecular Cancer Therapeutics. 11(4). 1036–1047. 57 indexed citations
9.
McTigue, Michele, Sergei Timofeevski, Wei Liu, et al.. (2011). Abstract 2327: Structural and kinetic characterization of crizotinib with wild-type and mutant anaplastic lymphoma kinase. Cancer Research. 71(8_Supplement). 2327–2327. 1 indexed citations
10.
Humphries, Paul S., Jennifer Lafontaine, David Alexánder, et al.. (2009). Synthesis and SAR of 4-substituted-2-aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(8). 2099–2102. 18 indexed citations
11.
Timofeevski, Sergei, Michele McTigue, Kevin Ryan, et al.. (2009). Enzymatic Characterization of c-Met Receptor Tyrosine Kinase Oncogenic Mutants and Kinetic Studies with Aminopyridine and Triazolopyrazine Inhibitors. Biochemistry. 48(23). 5339–5349. 75 indexed citations
12.
Chen, Tracy, Natasha M. Kablaoui, Sergei Timofeevski, et al.. (2009). Identification of small-molecule inhibitors of the JIP–JNK interaction. Biochemical Journal. 420(2). 283–296. 47 indexed citations
13.
Black, Shawn C., Dawn Kelly-Sullivan, Sergei Timofeevski, et al.. (2008). Pharmacological characterization of a small molecule inhibitor of c-Jun kinase. American Journal of Physiology-Endocrinology and Metabolism. 295(5). E1142–E1151. 22 indexed citations
14.
Timofeevski, Sergei, Jeffery J. Prusakiewicz, Carol A. Rouzer, & Lawrence J. Marnett. (2002). Isoform-Selective Interaction of Cyclooxygenase-2 with Indomethacin Amides Studied by Real-Time Fluorescence, Inhibition Kinetics, and Site-Directed Mutagenesis. Biochemistry. 41(30). 9654–9662. 17 indexed citations
15.
Cameron, Michael D., Sergei Timofeevski, & Steven D. Aust. (2000). Enzymology of Phanerochaete chrysosporium with respect to the degradation of recalcitrant compounds and xenobiotics. Applied Microbiology and Biotechnology. 54(6). 751–758. 162 indexed citations
16.
Timofeevski, Sergei, et al.. (2000). Substrate Specificity of Lignin Peroxidase and a S168W Variant of Manganese Peroxidase. Archives of Biochemistry and Biophysics. 373(1). 147–153. 28 indexed citations
17.
Timofeevski, Sergei, et al.. (1999). Addition of Veratryl Alcohol Oxidase Activity to Manganese Peroxidase by Site-Directed Mutagenesis. Biochemical and Biophysical Research Communications. 256(3). 500–504. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026